Month: February 2018

Exelixis, Inc . EXEL announced encouraging results from a phase II investigator-sponsored trial (“IST”) of cabozantinib for the first-line treatment of metastatic radioiodine (“RAI”)-refractory differentiated thyroid carcinoma (“DTC”). The trial is being conducted by the Center for Rare Cancers and Personalized Therapy at the Abramson Cancer Center of the University of Pennsylvania […]

First Data Corporation FDC reported fourth-quarter 2017 adjusted earnings of 44 cents per share, which came in line with the Zacks Consensus Estimate. The figure increased 12.8% on a year-over-year basis. […]

TrueCar, Inc. TRUE is slated to report fourth-quarter 2017 results on Feb 15 after the bell. Last quarter, the company’s earnings matched the Zacks Consensus Estimate. […]

Wyndham Worldwide Corporation WYN reported mixed fourth-quarter 2017 results wherein earnings surpassed the Zacks Consensus Estimate while revenues lagged the same. Adjusted earnings of $1.49 per share beat the consensus estimate of $1.35 by 10.4%. Also, the bottom line was up 9.6% year over year on the back of higher revenues as well as the company’s share repurchase program, partly offset by higher interest expenses […]

ExxonMobil Corporation XOM recently agreed to divest its 50% stake in the Scarborough gas field offshore Western Australia to Woodside Petroleum Ltd for $744 million. The gas field is located in the Carnarvon Basin. Divestment Rationale The divestment can shrink ExxonMobil's risky asset portfolio and give an opportunity to focus on comparatively cheaper offshore liquefied natural gas (“LNG”) prospects in Papua New Guinea, Mozambique and others […]

The Clorox Company CLX being a beneficiary of the recent tax reform, is looking forward to share the benefits with its shareholders. As a result, it accelerated the declaration of dividend increase, which usually occurs in May. […]

CNO Financial Group, Inc .’s CNO fourth-quarter 2017 adjusted earnings of 61 cents per share surpassed the Zacks Consensus Estimate by 48.8%. The bottom line also improved 74.3% year over year on the back of higher revenues. […]

MetLife, Inc .’s MET fourth-quarter 2017 operating earnings of $1.11 per share beat the Zacks Consensus Estimate by 0.91%. Also, the bottom line increased 3% year over year. MetLife, Inc […]

Shares of Catalyst Pharmaceuticals, Inc. CPRX increased almost 4% on Feb 13 after the company announced positive results from a recent Type C meeting with the FDA on the resubmission of a new drug application (NDA) for its marketed drug, Firdapse (amifampridine phosphate). Catalyst Pharma is looking to get Firdapse approved in the United States for treatment of Lambert-Eaton myasthenic syndrome (LEMS). […]

On February 14, 2018, we issued an updated report on ImmunoGen, Inc. IMGN . ImmunoGen reported fourth-quarter results on Feb 9, 2018 […]

BP plc BP has recently commenced production of oil and natural gas from the Atoll Phase One development, located off the coast of Egypt. The British energy giant made the gas field discovery during March 2015. […]

FLIR Systems Inc. ’s FLIR fourth-quarter 2017 adjusted earnings per share came in at 58 cents, surpassing the Zacks Consensus Estimate of 56 cents. The reported figure increased 11.5% from the prior-year quarter figure on the back of solid top-line growth […]

Abiomed, Inc. ABMD recently announced expanded FDA Pre-Market Approval (PMA) for its flagship Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps. With this expanded PMA, these heart pumps can now be used to treat heart failure associated with cardiomyopathy leading to cardiogenic shock, including peripartum and postpartum cardiomyopathy (PPCM). […]

Valentine’s Day is here and people are splurging on gifts. This year, spending is expected to hit the second highest in the 15-year history as Americans are expected to spend an average of $143.56 or a total of $19.6 billion, as per the National Retail Federation’s survey. This is up from $18.2 billion last year but lower than a record $19.7 billion seen in 2016. […]

Individuals ramp up purchases of things like candies, chocolates, cologne, greeting cards along with flowers and other such gifts to pamper their loved ones on Valentine’s Day. Demand for dining out also sees an uptick. This Valentine’s Day won’t be any different. […]

CMS Energy Corporation CMS reported fourth-quarter 2017 adjusted earnings per share of 51 cents which was in line with the Zacks Consensus Estimate of 51 cents. Quarterly earnings however surged 75.9% from the year-ago figure of 29 cents. Excluding the one-time tax reform’s impact of 52 cents, the company reported loss of a penny as against earnings of 28 cents per share in the year-ago quarter […]

Medtronic plc MDT is scheduled to report third-quarter fiscal 2018 results before the opening bell on Feb 20. Last quarter, the company delivered earnings ahead of the Zacks Consensus Estimate by 8.1%. In fact, Medtronic’s bottom line outpaced the estimates in all the trailing four quarters with an average beat of 3.55%. […]